Use of inhaled iloprost in an infant with bronchopulmonary dysplasia and pulmonary artery hypertensionopen access
- Authors
- Hwang, Seung-Kyung; O, Yung-Chul; Kim, Nam-Su; Park, Hyun Kyung; Yum, Myung-Kul
- Issue Date
- Aug-2009
- Publisher
- The Korean Society of Cardiology
- Keywords
- Bronchopulmonary dysplasia; Iloprost; Pulmonary hypertension
- Citation
- Korean Circulation Journal, v.39, no.8, pp.342 - 345
- Indexed
- SCOPUS
KCI
- Journal Title
- Korean Circulation Journal
- Volume
- 39
- Number
- 8
- Start Page
- 342
- End Page
- 345
- URI
- https://scholarworks.bwise.kr/hanyang/handle/2021.sw.hanyang/176382
- DOI
- 10.4070/kcj.2009.39.8.343
- ISSN
- 1738-5520
- Abstract
- Pulmonary artery hypertension is a common cardiovascular complication in preterm infants with bronchopulmonary dysplasia which is associated with increased morbidity and mortality. Inhaled iloprost is used as a therapeutic option in pulmonary hypertension, especially in adults. There have been but a few reports on the use of iloprost for neonates and infants. We report the case of a 5 month-old-male infant who received neonatal intensive care for 4 months due to respiratory distress syndrome and prematurity, during which he developed bronchopulmonary dysplasia. Echocardiography showed severe pulmonary hypertension. The initial treatment included respiratory support with high frequency oscillatory ventilation (HFOV); however, his clinical condition did not improve. Inhaled iloprost with sildenafil, an oral phosphodiesterase-5 inhibitor, was thus used. With the administration of iloprost and sildenafil, his condition improved and he was weaned from oxygen. Our clinical experience suggests that iloprost is a promising therapy for pulmonary hypertension, especially when inhaled nitric oxide is unavailable. Copyright ? 2009 The Korean Society of Cardiology.
- Files in This Item
-
- Appears in
Collections - 서울 의과대학 > 서울 소아청소년과학교실 > 1. Journal Articles
![qrcode](https://api.qrserver.com/v1/create-qr-code/?size=55x55&data=https://scholarworks.bwise.kr/hanyang/handle/2021.sw.hanyang/176382)
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.